Labshake search
Citations for Tocris :
1 - 11 of 11 citations for p38 since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Immunology 2022Quote: ... p38 inhibitor (p38i, SB203580, 10 μM, Tocris), ERK inhibitor (ERKi ...
-
bioRxiv - Cell Biology 2021Quote: ... p38 MAPK inhibitor SB203580 (3 uM, Tocris, #1202), JNK inhibitor SP600125 (20uM ...
-
bioRxiv - Neuroscience 2023Quote: ... P38 inhibitor (SB202190) (Tocris, cat. no.1264; 100nM).
-
bioRxiv - Cell Biology 2021Quote: ... 3 μM of p38 MAPK inhibitor SB203580 (Tocris, #1202) or NLRP3 inflammasome inhibitor MCC950 (1uM ...
-
bioRxiv - Immunology 2019Quote: ... inhibitor of p38 MAP kinase (SB203580, 10 μM, Tocris), inhibitor of ERK MAP kinase (PD90859 ...
-
bioRxiv - Cancer Biology 2020Quote: ... 10 nM SB 202190 (P38 inhibitor; Tocris Bioscience, Bristol, UK), 10 µM MK-2206 (AKT inhibitor ...
-
bioRxiv - Biochemistry 2022Quote: ... assays also included 10 μM of the selective P38 inhibitor SB239063 (Tocris)
-
bioRxiv - Cell Biology 2022Quote: ... confluent HUVEC were pretreated with p38 MAPK specific inhibitor (100nM, SB239063; TOCRIS) for at least 1hr prior to physiological SS ...
-
bioRxiv - Cancer Biology 2023Quote: ... a selection p38 MAP kinase inhibitor and 10 nM nicotinamide (Tocris Bioscience, Bristol, UK) for the first day of passaging to prevent anoikis ...
-
bioRxiv - Immunology 2020Quote: ... Inhibitors of cell signalling were added 30 min prior to cytokine stimulation: BIRB796 (10µM, p38 MAPK inhibitor, Tocris), PD98059 (50µM ...
-
bioRxiv - Cell Biology 2022Quote: The mitogen-activated protein kinase kinase 1/2 (MEK1/2) inhibitor U0126 and the p38 MAPK inhibitor SB203580 were purchased from Tocris Bioscience (Bristol ...